• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量的膳食异甘草素可改善 C57BL/6J 肥胖小鼠的胰岛素抵抗和非酒精性脂肪性肝病。

Dietary Isoliquiritigenin at a Low Dose Ameliorates Insulin Resistance and NAFLD in Diet-Induced Obesity in C57BL/6J Mice.

机构信息

Department of Food Science and Nutrition, Kyungpook National University, 1370 San-Kyuk Dong Puk-Ku, Daegu 41566, Korea.

Center for Food and Nutritional Genomics Research, Kyungpook National University, 1370 San-Kyuk Dong Puk-Ku, Daegu 41566, Korea.

出版信息

Int J Mol Sci. 2018 Oct 22;19(10):3281. doi: 10.3390/ijms19103281.

DOI:10.3390/ijms19103281
PMID:30360437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6214092/
Abstract

Isoliquiritigenin (ILG) is a flavonoid constituent of plants. The current study investigated the effects of ILG on diet-induced obesity and metabolic diseases. C57BL/6J mice were fed a normal diet (AIN-76 purified diet), high-fat diet (40 kcal% fat), and high-fat diet +0.02% (/) ILG for 16 weeks. Supplementation of ILG resulted in decreased body fat mass and plasma cholesterol level. ILG ameliorated hepatic steatosis by suppressing the expression of hepatic lipogenesis genes and hepatic triglyceride and fatty acid contents, while enhancing β-oxidation in the liver. ILG improved insulin resistance by lowering plasma glucose and insulin levels. This was also demonstrated by the intraperitoneal glucose tolerance test (IPGTT). Additionally, ILG upregulated the expression of insulin signaling-related genes in the liver and muscle. Interestingly, ILG elevated energy expenditure by increasing the expression of thermogenesis genes, which is linked to stimulated mitochondrial biogenesis and uncoupled cellular respiration in brown adipose tissue. ILG also suppressed proinflammatory cytokine levels in the plasma. These results suggest that ILG supplemented at 0.02% in the diet can ameliorate body fat mass, plasma cholesterol, non-alcoholic fatty liver disease, and insulin resistance; these effects were partly mediated by increasing energy expenditure in high-fat fed mice.

摘要

甘草查尔酮 B(ILG)是植物中的一种类黄酮成分。本研究探讨了 ILG 对饮食诱导肥胖和代谢性疾病的影响。C57BL/6J 小鼠喂食正常饮食(AIN-76 纯化饮食)、高脂肪饮食(40%脂肪)和高脂肪饮食+0.02%(/)ILG 16 周。补充 ILG 可降低体脂肪量和血浆胆固醇水平。ILG 通过抑制肝内脂质生成基因和肝内三酰甘油和脂肪酸含量,同时增强肝脏中的β氧化,改善肝脂肪变性。ILG 通过降低血浆葡萄糖和胰岛素水平来改善胰岛素抵抗。这也可以通过腹腔内葡萄糖耐量试验(IPGTT)来证明。此外,ILG 上调了肝脏和肌肉中胰岛素信号相关基因的表达。有趣的是,ILG 通过增加产热基因的表达来提高能量消耗,这与棕色脂肪组织中线粒体生物发生和解偶联细胞呼吸的刺激有关。ILG 还抑制了血浆中促炎细胞因子的水平。这些结果表明,饮食中补充 0.02%的 ILG 可以改善体脂肪量、血浆胆固醇、非酒精性脂肪肝和胰岛素抵抗;这些作用部分是通过增加高脂肪喂养小鼠的能量消耗来介导的。

相似文献

1
Dietary Isoliquiritigenin at a Low Dose Ameliorates Insulin Resistance and NAFLD in Diet-Induced Obesity in C57BL/6J Mice.低剂量的膳食异甘草素可改善 C57BL/6J 肥胖小鼠的胰岛素抵抗和非酒精性脂肪性肝病。
Int J Mol Sci. 2018 Oct 22;19(10):3281. doi: 10.3390/ijms19103281.
2
Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.长期低剂量服用诺必特可改善饮食诱导肥胖引起的肝脂肪变性、胰岛素抵抗和炎症,而不改变脂肪量。
Mol Nutr Food Res. 2017 Aug;61(8). doi: 10.1002/mnfr.201600889. Epub 2017 Mar 2.
3
Seabuckthorn Leaves Extract and Flavonoid Glycosides Extract from Seabuckthorn Leaves Ameliorates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obesity.沙棘叶提取物及沙棘叶黄酮糖苷提取物可改善饮食诱导肥胖中的肥胖、肝脂肪变性、胰岛素抵抗及炎症。
Nutrients. 2017 Jun 2;9(6):569. doi: 10.3390/nu9060569.
4
Platycodon grandiflorus Root Extract Attenuates Body Fat Mass, Hepatic Steatosis and Insulin Resistance through the Interplay between the Liver and Adipose Tissue.桔梗根提取物通过肝脏与脂肪组织之间的相互作用减轻体脂、肝脂肪变性和胰岛素抵抗。
Nutrients. 2016 Aug 30;8(9):532. doi: 10.3390/nu8090532.
5
Long-Term Dietary Supplementation with Yerba Mate Ameliorates Diet-Induced Obesity and Metabolic Disorders in Mice by Regulating Energy Expenditure and Lipid Metabolism.长期补充马黛茶可通过调节能量消耗和脂质代谢改善饮食诱导的小鼠肥胖和代谢紊乱。
J Med Food. 2017 Dec;20(12):1168-1175. doi: 10.1089/jmf.2017.3995. Epub 2017 Sep 5.
6
Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation.甘草素是一种有效的 NLRP3 炎性体激活和饮食诱导的脂肪组织炎症的抑制剂。
J Leukoc Biol. 2014 Dec;96(6):1087-100. doi: 10.1189/jlb.3A0114-005RR. Epub 2014 Sep 10.
7
Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.染料木黄酮通过调节饮食诱导的肥胖小鼠的肝脏脂质和葡萄糖代谢途径改善肝脂肪变性和胰岛素抵抗。
Mol Nutr Food Res. 2016 Sep;60(9):1944-55. doi: 10.1002/mnfr.201500689. Epub 2016 Jun 8.
8
Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.Nrg4 可促进燃料氧化和健康的脂肪细胞因子谱,改善饮食诱导的代谢紊乱。
Mol Metab. 2017 Jun 21;6(8):863-872. doi: 10.1016/j.molmet.2017.03.016. eCollection 2017 Aug.
9
Medium-chain triglyceride ameliorates insulin resistance and inflammation in high fat diet-induced obese mice.中链甘油三酯改善高脂饮食诱导的肥胖小鼠的胰岛素抵抗和炎症。
Eur J Nutr. 2016 Apr;55(3):931-40. doi: 10.1007/s00394-015-0907-0. Epub 2015 Apr 25.
10
Bavachin protects against diet-induced hepatic steatosis and obesity in mice.巴维亭可预防小鼠饮食诱导的肝脂肪变性和肥胖。
Acta Pharmacol Sin. 2023 Jul;44(7):1416-1428. doi: 10.1038/s41401-023-01056-z. Epub 2023 Jan 31.

引用本文的文献

1
Hesperetin and Isoliquiritigenin Attenuate the Progression of Diabetic Nephropathy via Inhibition of NF-κB/NLRP3 Pathways in Type 2 Diabetic Rats.橙皮素和异甘草素通过抑制2型糖尿病大鼠的NF-κB/NLRP3信号通路减轻糖尿病肾病进展
ACS Omega. 2025 Jul 30;10(31):34342-34351. doi: 10.1021/acsomega.5c02026. eCollection 2025 Aug 12.
2
IGFBP5 mediates the therapeutic effect of isoliquiritigenin in myocardial ischemia-reperfusion injury via AKT/GLUT4 regulated insulin resistance.胰岛素样生长因子结合蛋白5通过AKT/GLUT4调节的胰岛素抵抗介导异甘草素对心肌缺血再灌注损伤的治疗作用。
Front Pharmacol. 2025 Apr 29;16:1544869. doi: 10.3389/fphar.2025.1544869. eCollection 2025.
3

本文引用的文献

1
Isoliquiritigenin Ameliorates Acute Pancreatitis in Mice via Inhibition of Oxidative Stress and Modulation of the Nrf2/HO-1 Pathway.异甘草素通过抑制氧化应激和调节 Nrf2/HO-1 通路减轻小鼠急性胰腺炎。
Oxid Med Cell Longev. 2018 Apr 26;2018:7161592. doi: 10.1155/2018/7161592. eCollection 2018.
2
SIRT1 as a Therapeutic Target in Diabetic Complications.SIRT1 作为糖尿病并发症的治疗靶点。
Curr Med Chem. 2018;25(9):1002-1035. doi: 10.2174/0929867324666171107103114.
3
Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
Isoliquiritigenin Ameliorates High-Fat Diet-Induced Obesity in Mice by Activating Brown Adipose Tissue.
异甘草素通过激活棕色脂肪组织改善高脂饮食诱导的小鼠肥胖。
Int J Mol Sci. 2025 Feb 14;26(4):1616. doi: 10.3390/ijms26041616.
4
Preventive role of Pastinaca sativa in mitigating metabolic dysfunction-associated steatotic liver disease via modulation of metabolic endotoxemia.欧防风通过调节代谢性内毒素血症对减轻代谢功能障碍相关脂肪性肝病的预防作用。
NPJ Sci Food. 2025 Feb 6;9(1):20. doi: 10.1038/s41538-024-00366-8.
5
Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease.甘草查尔酮 B 联合内脏脂肪组织及其相关标志物作为预测非酒精性脂肪性肝病的工具。
J Physiol Biochem. 2024 Aug;80(3):639-653. doi: 10.1007/s13105-023-00998-6. Epub 2023 Nov 24.
6
Natural Chalcones for the Management of Obesity Disease.天然查耳酮类化合物在肥胖病管理中的应用。
Int J Mol Sci. 2023 Nov 3;24(21):15929. doi: 10.3390/ijms242115929.
7
Gut microbiota-mitochondrial inter-talk in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中肠道微生物群与线粒体的相互作用
Front Nutr. 2022 Sep 20;9:934113. doi: 10.3389/fnut.2022.934113. eCollection 2022.
8
Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition.NLRP3 炎性小体及其抑制剂作为阿尔茨海默病新兴治疗药物靶点的作用:激活、调控和抑制机制的综述。
Inflammation. 2023 Feb;46(1):56-87. doi: 10.1007/s10753-022-01730-0. Epub 2022 Aug 25.
9
Validation of a Quantification Method for Curcumin Derivatives and Their Hepatoprotective Effects on Nonalcoholic Fatty Liver Disease.姜黄素衍生物定量方法的验证及其对非酒精性脂肪性肝病的肝保护作用
Curr Issues Mol Biol. 2022 Jan 15;44(1):409-432. doi: 10.3390/cimb44010029.
10
ssp. MG741 Reduces Body Weight and Ameliorates Nonalcoholic Fatty Liver Disease via Improving the Gut Permeability and Amelioration of Inflammatory Cytokines.ssp. MG741 通过改善肠道通透性和减轻炎症细胞因子来减轻体重和改善非酒精性脂肪性肝病。
Nutrients. 2022 May 7;14(9):1965. doi: 10.3390/nu14091965.
异甘草素减轻载脂蛋白E缺陷小鼠的动脉粥样硬化形成。
Int J Mol Sci. 2016 Nov 18;17(11):1932. doi: 10.3390/ijms17111932.
4
Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?趋化因子CC基序配体4相关机制在糖尿病和心血管疾病中的新作用:是友还是敌?
Cardiovasc Diabetol. 2016 Aug 24;15(1):117. doi: 10.1186/s12933-016-0439-9.
5
Isoliquiritigenin impairs insulin signaling and adipocyte differentiation through the inhibition of protein-tyrosine phosphatase 1B oxidation in 3T3-L1 preadipocytes.异甘草素通过抑制3T3-L1前脂肪细胞中蛋白酪氨酸磷酸酶1B的氧化来损害胰岛素信号传导和脂肪细胞分化。
Food Chem Toxicol. 2016 Jul;93:5-12. doi: 10.1016/j.fct.2016.04.017. Epub 2016 Apr 23.
6
Isoliquiritigenin Attenuates Adipose Tissue Inflammation in vitro and Adipose Tissue Fibrosis through Inhibition of Innate Immune Responses in Mice.甘草查尔酮 A 通过抑制先天免疫反应减轻肥胖小鼠脂肪组织炎症和纤维化
Sci Rep. 2016 Mar 15;6:23097. doi: 10.1038/srep23097.
7
Is interleukin-1β a culprit in macrophage-adipocyte crosstalk in obesity?白细胞介素-1β是肥胖中巨噬细胞与脂肪细胞相互作用的罪魁祸首吗?
Adipocyte. 2015 Jan 7;4(2):149-52. doi: 10.4161/21623945.2014.979661. eCollection 2015 Apr-Jun.
8
Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance.肥胖导致脂联素基因的 DNA 过度甲基化,从而介导胰岛素抵抗。
Nat Commun. 2015 Jul 3;6:7585. doi: 10.1038/ncomms8585.
9
High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice.在C57BL/6j小鼠中,高脂饮食诱导的肥胖在肝脏出现炎症之前,先引发了脂肪组织的炎症。
Aging (Albany NY). 2015 Apr;7(4):256-68. doi: 10.18632/aging.100738.
10
Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance.棕色脂肪组织活性作为肥胖/胰岛素抵抗治疗的靶点。
Front Physiol. 2015 Jan 30;6:4. doi: 10.3389/fphys.2015.00004. eCollection 2015.